ASCO: Targeted RT Treats Certain Advanced Prostate Cancers
Outcomes improved for metastatic castration-resistant prostate cancer that is positive for prostate-specific membrane antigen
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.